efficacy
- Mar- 2021 -28 marzoEnglish
CanSino vaccine: 90.07% efficacy in serious diseases
CanSino Biologics Inc.‘s vaccine (Ad5-nCoV) is 90.07% effective in preventing serious illness…
Leer más »
CanSino Biologics Inc.‘s vaccine (Ad5-nCoV) is 90.07% effective in preventing serious illness…
Leer más »